Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 08 2023
02 08 2023
Historique:
received:
06
02
2023
accepted:
16
07
2023
medline:
4
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
Respiratory viruses that were suppressed through previous lockdowns during the COVID-19 pandemic have recently started to co-circulate with SARS-CoV-2. Understanding the clinical characteristics and symptomatology of different respiratory viral infections can help address the challenges related to the identification of cases and the understanding of SARS-CoV-2 variants' evolutionary patterns. Flu Watch (2006-2011) and Virus Watch (2020-2022) are household community cohort studies monitoring the epidemiology of influenza, respiratory syncytial virus, rhinovirus, seasonal coronavirus, and SARS-CoV-2, in England and Wales. This study describes and compares the proportion of symptoms reported during illnesses infected by common respiratory viruses. The SARS-CoV-2 symptom profile increasingly resembles that of other respiratory viruses as new strains emerge. Increased cough, sore throat, runny nose, and sneezing are associated with the emergence of the Omicron strains. As SARS-CoV-2 becomes endemic, monitoring the evolution of its symptomatology associated with new variants will be critical for clinical surveillance.
Identifiants
pubmed: 37532756
doi: 10.1038/s41598-023-38869-1
pii: 10.1038/s41598-023-38869-1
pmc: PMC10397315
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12511Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206602
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC 19070
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
BMJ. 2021 Jan 29;372:n288
pubmed: 33514508
Rev Med Virol. 2021 May;31(3):e2179
pubmed: 33035373
J Chem Inf Model. 2022 Jan 24;62(2):412-422
pubmed: 34989238
BMJ Open. 2021 Jun 23;11(6):e048042
pubmed: 34162651
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
PLoS One. 2020 Jun 23;15(6):e0234765
pubmed: 32574165
J Zhejiang Univ Sci B. 2021 Feb 15;22(2):87-98
pubmed: 33615750
Int J Epidemiol. 2017 Apr 1;46(2):e18
pubmed: 26940466
JAMA Netw Open. 2022 Jan 4;5(1):e2142796
pubmed: 35006245
Influenza Other Respir Viruses. 2018 Jan;12(1):171-182
pubmed: 28991409
Microbes Infect. 2020 Jul - Aug;22(6-7):236-244
pubmed: 32405236
Nat Commun. 2022 Nov 11;13(1):6856
pubmed: 36369151
PLoS One. 2021 Mar 4;16(3):e0247461
pubmed: 33661992
Microbiol Spectr. 2021 Oct 31;9(2):e0043021
pubmed: 34494861
J Infect Dis. 2021 May 28;223(10):1666-1670
pubmed: 33580259
Int J Infect Dis. 2021 Sep;110:29-35
pubmed: 34245886